DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

Recruiting

Phase 2

IHL-42XDReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

Sponsor:

Incannex Healthcare Ltd

Code:

NCT07635563

Conditions

Obstructive Sleep Apnea (OSA)

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamide

IHL-42X: 5 mg dronabinol + 125 mg acetazolamide

IHL-42X: 7.5 mg dronabinol + 125 mg acetazolamide

IHL-42X: 2.5 mg dronabinol + 250 mg acetazolamide

IHL-42X: 5 mg dronabinol + 250 mg acetazolamide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-13. This information was provided to ClinicalTrials.gov by Incannex Healthcare Ltd on 2026-07-27.